I'm LongbridgeAI, I can summarize articles.SAMSONITEshares rose approximately 3% after UBS and HSBC reiterated their Buy ratings. UBS reported a 15% YoY decline in 1Q26 adjusted EBITDA to USD109 million, below expectations, but forecasted low single-digit revenue growth for FY2026. HSBC noted 1Q26 sales were in line but EBITDA fell 11% short of forecasts, expecting sales to improve in 2H26. Both brokers adjusted their target prices, with UBS lowering it to HKD20.6 and HSBC to HKD19, while maintaining Buy ratings amid ongoing travel disruptions due to Middle East conflicts.
SAMSONITE (01910.HK) +0.360 (+2.630%) Short selling $7.26M; Ratio 5.148% opened 2.63% higher today and once peaked at HKD14.25. It last traded at HKD14.08, up 2.85%, with turnover of 6.4101 million shares, involving HKD89.3831 million.
UBS said in a research report that SAMSONITE's 1Q26 adjusted EBITDA was USD109 million, down 15% YoY and below both the broker's and market's expectations, in wake of lower-than-expected gross margin. Adjusted EBITDA margin was 13.1%, below UBS forecast of 14.2%, primarily because SG&A expenses hiked 9% YoY, more than expected.
However, the group guided for low single-digit revenue growth for FY2026 and expected margins to gradually improve from the 1Q26 level, which was better than market concerns. The broker cut its TP to HKD20.6 from HKD22.7 and reiterated a Buy rating.
******************************************************************************************
HSBC Global Investment Research said in a report that SAMSONITE's 1Q26 sales were broadly in line, but adjusted EBITDA was 11% below market forecasts, with 2Q sales trends similar to those in 1Q. The broker expected sales to improve in 2H26 and margins to gradually recover.
SAMSONITE's near-term outlook remains challenging as ongoing conflicts in the Middle East keep disrupting travel trends. Management expected 2Q sales trends to be similar to those in 1Q26, with improvement in 2H26, driving low single-digit sales growth for full-year 2026.
The broker lowered its earnings forecasts for FY2026-27 by about 9%. It reduced its TP to HKD19 from HKD24 and maintained a Buy rating.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-13 16:25.)